Promptu Systems Corporation
US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)
US Synthetic Corporation
Achieving precedent in preserving valuable patents for Lumify®
Eye Therapies, LLC
Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Experience
Acted for an airport company in LCIA arbitration involving disclosures of confidential information* Acted for an airport company in LCIA arbitration involving disclosures of confidential information*
Experience
Defended a global aerospace and defence company in an ICC arbitration claim on misappropriation of confidential information in breach of a non-disclosure agreement* Defended a global aerospace and defence company in an ICC arbitration claim on misappropriation of confidential information in breach of a non-disclosure agreement*
Experience
Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand* Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand*
Experience
Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products* Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*
Experience
Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias* Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*
Experience
Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers* Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*
Experience
Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company* Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company*
Experience
Regeneron Pharmaceuticals Inc v. Kymab Ltd.* Regeneron Pharmaceuticals Inc v. Kymab Ltd.*
[2020] UKSC 27, Appeal number: UKSC 2018/0131, Supreme Court of the United Kingdom
Experience
Represented a global pharmaceutical company against a generic company on a patent covering an injectable painkilling medicine for short-term pain relief* Represented a global pharmaceutical company against a generic company on a patent covering an injectable painkilling medicine for short-term pain relief*
Experience
Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer* Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*
Experience
Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia* Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.